AstraZeneca Pharma India · NSE: ASTRAZEN · BSE: 506820
Q1 FY19 results · Apr–Jun 2018
AstraZeneca Pharma India reported revenue from operations of ₹161.44 crore and net profit of ₹6.39 crore for Q1 FY19 (Apr–Jun 2018), on a standalone basis.
| Item | Q1 FY19 | Q1 FY18 | YoY | Q4 FY18 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 161.44 | — | — | — | — |
| Other income | 3.42 | — | — | — | — |
| Total income | 164.86 | — | — | — | — |
| Profit before tax | 9.15 | — | — | — | — |
| Net profit for the period | 6.39 | — | — | — | — |
| EPS, basic (₹) | 2.56 | — | — | — | — |
| Net margin (%) | 4.0 | — | — |
Standalone
- Filed with BSE
- 20 Aug 2018, 12:08 IST
- Board meeting
- 13 Aug 2018
- Period
- 01 Apr 2018 to 30 Jun 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE